Sign up
Pharma Capital

LexaGene Holdings reports favorable beta test results on its infectious disease diagnostic in animals

LexaGene Holdings Inc (OTCQB: LXXGF)(CVE: LXG) CEO and Founder Dr Jack Regan tells Proactive Investors the biotech company has reported favorable beta test results from its infectious disease diagnostic analyzer in animals at the Massachusetts Veterinary Referral Hospital.

Dr. Regan says the company's test returns results are produced in about one hour versus three or more days.

 

View full LXG profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.